News of Note—NIH Zika vaccine, Emergent BioSciences and more

Here is some other vaccine news of note for this week.

> A team from George Washington University is testing an NIH-developed Zika vaccine in Brazil. Release

> NIAID Director Anthony Fauci, M.D., believes a "durable" end to the HIV and AIDS epidemic will require an effective vaccine. Release

> Ex-GSK vaccine and pharma exec Abbas Hussain joined C-Bridge Capital as a senior partner. FierceBiotech story

Emergent BioSciences finished its purchase of Sanofi's smallpox vaccine unit. Release

> A study found that AstraZeneca's FluMist was 46% effective, but a flu expert cited concerns. CIDRAP story

> Enesi Pharma launched with the goal to develop novel solid-dose vaccines against various diseases. Release

> In a recent survey, 87% of physicians said they believe GlaxoSmithKline's Shingrix is an important vaccine development. Medscape story